UPDATE 2-Bristol profit tops forecast, scales back 2013 ambitions
January 24, 2013 at 10:42 AM EST
*Sales $4.19 bln vs Street view $4.12 bln. Jan 24- Bristol-Myers Squibb Co reported better-than-expected quarterly results on Thursday, lifting its shares 2.7 percent, but scaled back its 2013 earnings forecast following setbacks for several of its experimental drugs.